Back to all Companies
/
Alzheon, Inc. | Preserving Future Memories
Followers on Linkedin
4503
HQ location
Framingham, US
Industry
Biotechnology

Alzheon, Inc. develops innovative medicines for neurodegenerative disorders, with a focus on their lead Alzheimer’s candidate, ALZ-801. This oral tablet blocks neurotoxic amyloid oligomers and builds on the safety and efficacy of tramiprosate.

Explore More Companies